TY  - RPRT
TI  - Randomized, multicenter, open-label phase II study of gemcitabine plus single-dose versus split-dose carboplatin in the treatment of patients with advanced-stage non-small-cell lung cancer.
AU  - Wolfgang Schuette
AU  - Thomas Blankenburg
AU  - Claus-Peter Schneider
AU  - Ludwig Fischer von Weikersthal
AU  - Sylvia Guetz
AU  - Gerhard Laier-Groeneveld
AU  - Johann Christian Virchow
AU  - Assnad Chemaissani
AU  - Martin Reck
PY  - 2006
DO  - 10.3816/clc.2006.n.042
UR  - https://pubmed.ncbi.nlm.nih.gov/17026815/
ID  - 17026815
ER  -